COVID-19 vaccination in patients with cancer: Opportunities and challenges.

ABSTRACT: The rapid spread of the SARS-Cov-2 virus, the increase in the number of patients with severe COVID-19, and the high mortality rate created the basis for the production of safe and effective vaccines. Studies have confirmed the increased risk of severe Covid-19 disease and mortality in cancer patients. It is logical that cancer patients should be the first to receive the primary vaccination and the booster vaccine for Covid-19. Since studies related to cancer patients and the effectiveness of existing Covid-19 vaccines have not been widely conducted, there are significant uncertainties about the effectiveness of the vaccine and the level of humoral and cellular immune responses in these patients. As a result, the possible risks and side effects of existing vaccines are not clear for patient

SUBMITTER: Al-Qaim ZH 

PROVIDER: S-EPMC9679654 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature